MannKind Corporation (MUN:NNFN) Financings

MannKind Corporation

Financings

RaiseDate
Private placement of unstated
Closed: US$50M raised · US$3.89 a share
Buyers: Frazier Life Sciences
Use of proceeds: To fund the $45 million CVR payment triggered by the FDA approval of Furoscix ReadyFlow
Aug 5, 2026

Read by 6ix AI from the company's releases